A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients-Reference-Cited by-同舟云学术

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients

Published:2021-01 Issue:1 Volume:10 Page:80-92
ISSN:2218-6751
Container-title:Translational Lung Cancer Research
language:
Short-container-title:Transl Lung Cancer Res

Author:

Rossi Elisabetta,Aieta Michele,Tartarone Alfredo,Pezzuto Aldo,Facchinetti Antonella,Santini Daniele,Ulivi Paola,Ludovini Vienna,Possidente Luciana,Fiduccia Pasquale,Minicuci Nadia,Zamarchi Rita

Publisher

AME Publishing Company

Subject

Oncology

Link

https://tlcr.amegroups.com/article/download/48350/pdf

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy Improves the Survival of Stage 4 Non–Small Cell Lung Cancer Patients at the US Population Level: The Real‐World Evidence;The Clinical Respiratory Journal;2024-09

2. The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature;Monaldi Archives for Chest Disease;2024-07-26

3. Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions;Biomedicines;2024-01-27

4. ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment;Biomedicines;2024-01-10

5. Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2023-11-08